BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS ArticleDiakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.Medical Technologies. Assessment and Choice. 2019. P.. 71-80
QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS ArticleIvanov D.A., Kubaeva M.B., Zyryanov S.K.Фармакоэкономика: теория и практика. Vol. 7. 2019. P.. 38-39
CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH ArticleTolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 11. 2019. P.. 48-60
GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION? ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Vol. 10. 2018. P.. 75-80
PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS ArticleZyryanov S.K., Cheberda A.E., Belousov D.Y.Rational Pharmacotherapy in Cardiology. Vol. 14. 2018. P.. 167-175
MODERN MASKS OF INFECTIOUS ENDOCARDITIS ArticleRodoman G.V., Sumedi I.R., Zyryanov S.K., Ivzhits M.A., Kurmashev A.F., Ionidi P.V., Putsman G.A., Kuchuk A.O.Antibiotiki i Khimioterapiya. Vol. 63. 2018. P.. 18-27
PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY ArticleBobrova O.P., Dyhno Y.A., Shnayder N.A., Petrova M.M., Zyryanov S.K.Siberian Journal of Oncology. Vol. 17. 2018. P.. 94-100
PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD ArticleZyryanov S.K., D'yakov I.N.Pulmonologiya. Vol. 28. 2018. P.. 61-68
PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER ArticleFedyayev D.V., Zyryanov S.K.Medical Technologies. Assessment and Choice. 2018. P.. 68-84
LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE ArticleZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.Antibiotiki i Khimioterapiya. Vol. 63. 2018. P.. 46-51
THERAPY OF BRONCHIAL ASTHMA IN CHILDREN: INHALED CORTICOSTEROIDS VS. ANTAGONISTS OF LEUKOTRIENE RECEPTORS (LITERATURE REVIEW) ArticlePereverzev A.P., Zyryanov S.K., Ushkalova E.A., Cheltsov V.V.Consilium Medicum. Vol. 20. 2018. P.. 40-44
EXTRACELLULAR DNA AND PLASMA NUCLEASE ACTIVITY EFFECT ON THE COURSE OF THE MICROBIAL INFLAMMATORY PROCESS IN THE RESPIRATORY TRACT IN CYSTIC FIBROSIS ArticleKondratieva E.I., Kondakova Yu.A., Kostyuk S.V., Ershova E.V., Zyryanov S.K., Melyanovskaya Yu.L., Voronkova A.Yu., Sherman V.D., Shadrina V.V.Journal of Bioinformatics and Genomics. 2018. 2 p..
ПРОГНОЗНЫЙ ЭКОНОМИЧЕСКИЙ ЭФФЕКТ ПРИМЕНЕНИЯ АЛИРОКУМАБА У ПАЦИЕНТОВ С ГИПЕРХОЛЕСТЕРИНЕМИЕЙ И ВЫСОКИМ СЕРДЕЧНО-СОСУДИСТЫМ РИСКОМ ArticleЗырянов С.К., Дьяков И.Н.Клиническая фармакология и терапия. Vol. 27. 2018. P.. 90-96
CLINICAL AND ECONOMIC EVALUATION OF USING FIXED DOSE DUAL BRONCHODILATOR COMBINATION TIOTROPIUMOLODATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ArticleZyryanov S.K., Galatonova Y.A.Медицинский совет. 2018. P.. 61-65
GCP INSPECTION BY ROSZDRAVNADZOR ArticleBelousov D.Yu., Zyryanov S.K., Kolbin A.S., Karpenko L.I., Rogov E.S.Качественная клиническая практика. 2018. P.. 66-76
PHARMACOECONOMICS EXPEDIENCY OF APPLICATION OF THE COMBINED PREPARATION OF VEZOMNI IN COMPARISON WITH A COMBINATION OF TAMSULOSIN AND SOLIFENACIN IN THE FORM OF MONOPREPARATIONS ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2018. P.. 35-40
PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA ArticleCheberda A.E., Belousov D.Yu., Zyryanov S.K.Качественная клиническая практика. 2018. P.. 53-65
PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA ArticleZyryanov S.K., Zatolochina K.E.Качественная клиническая практика. 2018. P.. 51-57
РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ "ЭМПИРИЧЕСКАЯ АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ИНФЕКЦИЙ ДЫХАТЕЛЬНЫХ ПУТЕЙ С УЧЕТОМ ФАКТОРОВ РИСКА РЕЗИСТЕНТНОЙ ФЛОРЫ" ArticleКозлов Р.С., Зырянов С.К., Синопальников А.И., Рязанцев С.В., Стырт Е.А.Справочник поликлинического врача. 2018. P.. 28-32
METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Kardiologiia. Vol. 58. 2018. P.. 82-93
GENETICALLY ENGINEERED DRUGS FOR TREATMENT OF BRONCHIAL ASTHMA: RECENT ACHIEVEMENTS ArticleZyryanov S.K., Butranova O.I.Pulmonologiya. Vol. 28. 2018. P.. 584-601
A PROBLEM OF INHALED DRUG SUBSTITUTIONS: AN ANALYSIS OF DATA FROM RUSSIAN DATABASE ON ADVERSE EVENTS ArticleZyryanov S.K., Zatolochina K.E., Asetskaya I.L.Pulmonologiya. Vol. 28. 2018. P.. 424-429
IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII] ArticleZyryanov S.K., Butranova O.I., Ramenskaya G.V., Gildeeva G.N., Shohin I.E.Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Vol. 118. 2018. P.. 43-48
CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME ArticleBobrova O.P., Shnayder N.A., Zyryanov S.K., Dykhno Y.A., Petrova M.M., Nasyrova R.F.Siberian Journal of Oncology. Vol. 17. 2018. P.. 114-122
ФАРМАКОЭКОНОМИЧЕСКОЕ ИССЛЕДОВАНИЕ ПРЕПАРАТОВ, ПРИМЕНЯЕМЫХ ПРИ ЛЕЧЕНИИ ПСОРИАЗА СРЕДНЕТЯЖЕЛОЙ И ТЯЖЕЛОЙ СТЕПЕНИ У ПАЦИЕНТОВ С НЕЭФФЕКТИВНОСТЬЮ БАЗОВОЙ СИСТЕМНОЙ ТЕРАПИИ ArticleЗырянов С.К., Чеберда А.Е., Белоусов Д.Ю.Клиническая фармакология и терапия. Vol. 27. 2018. P.. 91-97
PRINCIPLES OF SELECTION AND DOSING OF ANTIBACTERIAL AGENTS IN PATIENTS WITH HEPATIC FAILURE ArticleUshkalova E.A., Zyryanov S.K., Pereverzev A.P.Хирург. 2018. P.. 75-88
HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2 ArticleZiryanov S.K., Dyakov I.N.Качественная клиническая практика. 2018. P.. 4-13
PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION ArticleAsetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.Качественная клиническая практика. 2018. P.. 53-72
OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY BASED ON A PERSONALIZED APPROACH TO DRUG SAFETY ASSESSMENT ArticleBochanova E.N., Shnayder N.A., Zyryanov S.K., Gusev S.D., Nasyrova R.F.Доктор.Ру. 2018. P.. 13-18
CLINICAL CASE OF NON-IMMUNE HYDROPS FETALIS CONGENITAL SYPHILIS ATPRETERMINFANT ArticleShulakova O.A., Karabanov A.M., Zyryanov S.M., Gurevitch K.G.Неонатология: новости, мнения, обучение. 2018. P.. 83-87
SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL ArticleZyryanov S.K., Baibulatova E.A.Лечебное дело. 2018. P.. 50-61
PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS ArticleDyrina K.S., Uvarova E.S., Kutsaya K.O., Zyryanov S.K., Zyryanov S.K.Клинические и теоретические аспекты современной медицины. 2018. 69 p..
THE MONITORING OF DRUG USE SAFETY IN THE MULTISPECIALITY HOSPITAL ArticleZyryanov S.K., Ivzhits M.A., Ivanov D.A.Хирург. 2018. P.. 73-79
MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION ArticleZyryanov S.K., Sychyov I.N.Хирург. 2018. P.. 31-43
DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY ArticleZyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Vol. 9. 2017. P.. 4-10
CLINICAL AND PHARMACOLOGICAL COMPARISON OF CURRENT ANTIFIBROTIC DRUGS FOR THERAPY OF IDIOPATHIC PULMONARY FIBROSIS ArticleZyryanov S.K., Butranova O.I., Shatalova O.V.Pulmonologiya. Vol. 27. 2017. P.. 789-802
PHARMACOECONOMIC STUDY OF THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ADULT PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN RUSSIAN FEDERATION ArticleKrysanov I.S., Zyryanov S.K., Krysanova V.S.Gematologiya i Transfuziologiya. Vol. 62. 2017. P.. 20-25
COULD INHALATIONAL DRUGS BE INTERCHANGEABLE? ArticleZyryanov S.K., Zatolochina K.E., Cheltsov V.V.Pulmonologiya. Vol. 27. 2017. P.. 529-536
CURRENT PROBLEMS OF INFECTIONS CAUSED BY MRSA AND WAYS TO ADDRESS THEM ArticleZyryanov S.K., Sychev N., Gushchina Yu.Sh.Antibiotiki i Khimioterapiya. Vol. 62. 2017. P.. 69-79
VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ArticleDyakov I.N., Zyryanov S.K.Vestnik Oftalmologii. Vol. 133. 2017. P.. 125-129
THE EFFICACY AND SAFETY OF VALPROIC ACID MEDICATIONS WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN ADULTS IN REAL CLINICAL PRACTICE FROM THE POSITION OF PHARMACOKINETIC AND PHARMACOGENETIC APPROACHES ArticleVlasov P.N., Orekhova N.V., Antonyuk M.V., Filatova N.V., Schnaider N.A., Dmitrenko D.V., Zobova S.N., Poverennova I.E., Yakunina A.V., Kalinin V.A., Zyryanov S.K., Tishchenkova I.F.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Vol. 9. 2017. P.. 11-20
АНТИГИПЕРТЕНЗИВНАЯ ТЕРАПИЯ: ОТ КЛИНИЧЕСКОЙ ФАРМАКОЛОГИИ ДО КЛИНИЧЕСКОГО РЕЗУЛЬТАТА. ИЛИ ЧТО ВАЖНО ЗНАТЬ, ВЫБИРАЯ АНТИГИПЕРТЕНЗИВНЫЙ ПРЕПАРАТ ArticleЗырянов С.К., Бутранова О.И.Сердце: журнал для практикующих врачей. Vol. 16. 2017. P.. 286-297
КЛИНИКО-ФАРМАКОЛОГИЧЕСКОЕ ОБОСНОВАНИЕ ВАРИАБЕЛЬНОСТИ АНТИАГРЕГАНТНОГО ОТВЕТА ПРИ ИСПОЛЬЗОВАНИИ РАЗНЫХ ЛЕКАРСТВЕННЫХ ФОРМ АЦЕТИЛСАЛИЦИЛОВОЙ КИСЛОТЫ ArticleЗырянов С.К., Бутранова О.И.Consilium Medicum. Vol. 19. 2017. P.. 105-112
ПРОГРАММА СКАТ (СТРАТЕГИЯ КОНТРОЛЯ АНТИМИКРОБНОЙ ТЕРАПИИ) ПРИ ОКАЗАНИИ СТАЦИОНАРНОЙ МЕДИЦИНСКОЙ ПОМОЩИ. МЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИ ДЛЯ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКИХ УЧРЕЖДЕНИЙ МОСКВЫ ArticleЯковлев С.В., Журавлева М.В., Проценко Д.Н., Белобородов В.Б., Брико Н.И., Брусина Е.Б., Гусаров В.Г., Елисеева Е.В., Замятин М.Н., Зырянов С.К., Кукес В.Г., Попов Д.А., Сидоренко С.В., Суворова М.П.Consilium Medicum. Vol. 19. 2017. P.. 15-51
EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION ArticleЗырянов С.К., Переверзев А.П.Российский кардиологический журнал. 2017. P.. 158-163
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION ArticleУшкалова Е.А., Зырянов С.К., Думченко Е.В.Rational Pharmacotherapy in Cardiology. Vol. 13. 2017. P.. 275-283
ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY ArticleУшкалова Е.А., Зырянов С.К., Думченко Е.В.Rational Pharmacotherapy in Cardiology. Vol. 13. 2017. P.. 124-128
НОВЫЕ ВОЗМОЖНОСТИ В ПРОФИЛАКТИКЕ ОБОСТРЕНИЙ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ. ЗАКЛЮЧЕНИЕ ГРУППЫ СПЕЦИАЛИСТОВ РОССИЙСКОГО РЕСПИРАТОРНОГО ОБЩЕСТВА ArticleАвдеев С.Н., Айсанов З.Р., Белевский А.С., Визель А.А., Зырянов С.К., Игнатова Г.Л., Княжеская Н.П., Лещенко И.В., Овчаренко С.И., Синопальников А.И., Степанян И.Э., Трофимов В.И.Pulmonologiya. Vol. 27. 2017. P.. 108-113
УГНЕТЕНИЕ ФИБРОБЛАСТОВ МОДИФИЦИРУЕТ ИНТЕНСИВНОСТЬ СПАЙКООБРАЗОВАНИЯ ПРИ АСЕПТИЧЕСКОМ ВОСПАЛЕНИИ БРЮШИНЫ КРОЛИКОВ ArticleСкальский С.В., Соколова Т.Ф., Зырянов С.К.Успехи современной науки. Vol. 5. 2017. P.. 153-158